RecruitingPhase 1NCT04713657

Beta-blocker Administration for Cardiomyocyte Division

Studying Tetralogy of Fallot

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Weill Medical College of Cornell University
Principal Investigator
Bernhard Kuhn, MD
Weill Medical College of Cornell University
Intervention
N-thymidine(other)
Enrollment
40 enrolled
Eligibility
All sexes
Timeline
20222030

Study locations (3)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04713657 on ClinicalTrials.gov

Other trials for Tetralogy of Fallot

Additional recruiting or active studies for the same condition.

See all trials for Tetralogy of Fallot

← Back to all trials